BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Sudfeld CR, Giovannucci EL, Isanaka S, Aboud S, Mugusi FM, Wang M, Chalamilla G, Fawzi WW. Vitamin D status and incidence of pulmonary tuberculosis, opportunistic infections, and wasting among HIV-infected Tanzanian adults initiating antiretroviral therapy. J Infect Dis 2013;207:378-85. [PMID: 23162137 DOI: 10.1093/infdis/jis693] [Cited by in Crossref: 57] [Cited by in F6Publishing: 60] [Article Influence: 5.2] [Reference Citation Analysis]
Number Citing Articles
1 Vanvalkenburg A, Kaipilyawar V, Sarkar S, Lakshminarayanan S, Cintron C, Prakash Babu S, Knudsen S, Joseph NM, Horsburgh CR, Ellner JJ, Narasimhan PB, Johnson WE, Hochberg NS, Salgame P. Malnutrition leads to increased inflammation and expression of tuberculosis risk signatures in recently exposed household contacts of pulmonary tuberculosis. Front Immunol 2022;13:1011166. [DOI: 10.3389/fimmu.2022.1011166] [Reference Citation Analysis]
2 Buyukdemirci S, Oguz EG, Cimen SG, Sahin H, Cimen S, Ayli MD. Vitamin D deficiency may predispose patients to increased risk of kidney transplant rejection. World J Transplant 2022; 12(9): 299-309 [DOI: 10.5500/wjt.v12.i9.299] [Reference Citation Analysis]
3 Verma P, Shrivastava A, Siddiqui SA, Yadav RK, Singh MV, Tripathi A, Maurya M, Mishra N. Effect of Vitamin D Supplementation on CD4 Count in HIV-Infected Children and Adolescents in North India: A Non-Randomized Comparative Study. J Trop Pediatr 2022;68:fmac066. [PMID: 35944184 DOI: 10.1093/tropej/fmac066] [Reference Citation Analysis]
4 Sudfeld CR, Manji KP, Muhihi A, Duggan CP, Aboud S, Alwy Al-Beity FM, Wang M, Zhang N, Ulenga N, Fawzi WW. Vitamin D3 supplementation during pregnancy and lactation for women living with HIV in Tanzania: A randomized controlled trial. PLoS Med 2022;19:e1003973. [PMID: 35427363 DOI: 10.1371/journal.pmed.1003973] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
5 Piloya TW, Bakeera-Kitaka S, Kisitu GP, Idro R, Cusick SE. Vitamin D status and associated factors among HIV-infected children and adolescents on antiretroviral therapy in Kampala, Uganda. PLoS One 2021;16:e0253689. [PMID: 34166428 DOI: 10.1371/journal.pone.0253689] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
6 Chokuda E, Reynolds C, Das S. Association of Low Vitamin D with Complications of HIV and AIDS: A literature Review. Infect Disord Drug Targets 2020;20:122-42. [PMID: 30574856 DOI: 10.2174/1871526519666181221122731] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
7 Sudfeld CR, Mugusi F, Muhihi A, Aboud S, Nagu TJ, Ulenga N, Hong B, Wang M, Fawzi WW. Efficacy of vitamin D3 supplementation for the prevention of pulmonary tuberculosis and mortality in HIV: a randomised, double-blind, placebo-controlled trial. Lancet HIV 2020;7:e463-71. [PMID: 32621874 DOI: 10.1016/S2352-3018(20)30108-9] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 6.0] [Reference Citation Analysis]
8 Reuter A, Furin J. The problem with vitamin D supplementation for tuberculosis. Lancet HIV 2020;7:e450-1. [PMID: 32621871 DOI: 10.1016/S2352-3018(20)30114-4] [Reference Citation Analysis]
9 Lee S, Lee JE, Lee SO, Sim YK, Lee SH. Influence of Vitamin D Deficiency on the Development of Opportunistic Infection in People Living with HIV/AIDS (PWHAs). Journal of the American College of Nutrition 2021;40:545-50. [DOI: 10.1080/07315724.2020.1805043] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
10 Noor RA, Abioye AI, Hertzmark E, Darling AM, Aboud S, Mugusi FM, Sudfeld CR, Spiegelman D, Fawzi WW. Impaired Hematological Status Increases the Risk of Mortality among HIV-Infected Adults Initiating Antiretroviral Therapy in Tanzania. J Nutr 2020;150:2375-82. [PMID: 32621487 DOI: 10.1093/jn/nxaa172] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
11 Aibana O, Huang CC, Aboud S, Arnedo-Pena A, Becerra MC, Bellido-Blasco JB, Bhosale R, Calderon R, Chiang S, Contreras C, Davaasambuu G, Fawzi WW, Franke MF, Galea JT, Garcia-Ferrer D, Gil-Fortuño M, Gomila-Sard B, Gupta A, Gupte N, Hussain R, Iborra-Millet J, Iqbal NT, Juan-Cerdán JV, Kinikar A, Lecca L, Mave V, Meseguer-Ferrer N, Montepiedra G, Mugusi FM, Owolabi OA, Parsonnet J, Roach-Poblete F, Romeu-García MA, Spector SA, Sudfeld CR, Tenforde MW, Togun TO, Yataco R, Zhang Z, Murray MB. Vitamin D status and risk of incident tuberculosis disease: A nested case-control study, systematic review, and individual-participant data meta-analysis. PLoS Med 2019;16:e1002907. [PMID: 31509529 DOI: 10.1371/journal.pmed.1002907] [Cited by in Crossref: 72] [Cited by in F6Publishing: 72] [Article Influence: 18.0] [Reference Citation Analysis]
12 Choi YJ, Lim YH, Lee KS, Hong YC. Elevation of ambient temperature is associated with an increased risk of herpes zoster: a time-series analysis. Sci Rep 2019;9:12254. [PMID: 31439885 DOI: 10.1038/s41598-019-48673-5] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
13 Hsieh E, Yin MT. Continued Interest and Controversy: Vitamin D in HIV. Curr HIV/AIDS Rep 2018;15:199-211. [PMID: 29713871 DOI: 10.1007/s11904-018-0401-4] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 3.5] [Reference Citation Analysis]
14 Bivona G, Agnello L, Lo Sasso B, Scazzone C, Butera D, Gambino CM, Iacolino G, Bellia C, Ciaccio M. Vitamin D in malaria: more hypotheses than clues. Heliyon 2019;5:e01183. [PMID: 30793054 DOI: 10.1016/j.heliyon.2019.e01183] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 3.0] [Reference Citation Analysis]
15 Aibana O, Huang C, Aboud S, Arnedo-pena A, Becerra MC, Bellido-blasco JB, Bhosale R, Calderon R, Chiang S, Contreras C, Davaasambuu G, Fawzi WW, Franke MF, Galea JT, Garcia-ferrer D, Gil-fortuño M, Gomila-sard B, Gupta A, Gupte N, Hussain R, Iborra-millet J, Iqbal NT, Juan-cerdán JV, Kinikar A, Lecca L, Mave V, Meseguer-ferrer N, Montepiedra G, Mugusi FM, Owolabi OA, Parsonnet J, Roach-poblete F, Romeu-garcía MA, Spector SA, Sudfeld CR, Tenforde MW, Togun TO, Yataco R, Zhang Z, Murray MB. Vitamin D status and risk of incident tuberculosis disease: a systematic review and individual participant data meta-analysis.. [DOI: 10.1101/481739] [Reference Citation Analysis]
16 Afzal A, Rathore R, Butt NF, Randhawa FA. Efficacy of Vitamin D supplementation in achieving an early Sputum Conversion in Smear positive Pulmonary Tuberculosis. Pak J Med Sci 2018;34:849-54. [PMID: 30190740 DOI: 10.12669/pjms.344.14397] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 1.6] [Reference Citation Analysis]
17 Abhimanyu, Coussens AK. The role of UV radiation and vitamin D in the seasonality and outcomes of infectious disease. Photochem Photobiol Sci 2017;16:314-38. [PMID: 28078341 DOI: 10.1039/c6pp00355a] [Cited by in Crossref: 63] [Cited by in F6Publishing: 65] [Article Influence: 12.6] [Reference Citation Analysis]
18 Gayatri YAAA, Sukmawati DD, Utama SM, Somia IKA, Merati TP. Hypovitaminosis D increases TB co-infection risk on HIV patients. IOP Conf Ser : Earth Environ Sci 2018;125:012097. [DOI: 10.1088/1755-1315/125/1/012097] [Reference Citation Analysis]
19 Aibana O, Franke MF, Huang CC, Galea JT, Calderon R, Zhang Z, Becerra MC, Smith ER, Ronnenberg AG, Contreras C, Yataco R, Lecca L, Murray MB. Impact of Vitamin A and Carotenoids on the Risk of Tuberculosis Progression. Clin Infect Dis 2017;65:900-9. [PMID: 28531276 DOI: 10.1093/cid/cix476] [Cited by in Crossref: 55] [Cited by in F6Publishing: 56] [Article Influence: 11.0] [Reference Citation Analysis]
20 Dragonas P, Kaste LM, Nunn M, Gajendrareddy PK, Weber KM, Cohen M, Adeyemi OM, French AL, Sroussi HY. Vitamin D deficiency and periodontal clinical attachment loss in HIV-seropositive women: A secondary analysis conducted in the Women's Interagency HIV Study (WIHS). Oral Surg Oral Med Oral Pathol Oral Radiol 2018;125:567-73. [PMID: 29550079 DOI: 10.1016/j.oooo.2018.02.006] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
21 Martineau AR, Jolliffe DA, Demaret J. Vitamin D and Tuberculosis. Vitamin D 2018. [DOI: 10.1016/b978-0-12-809963-6.00103-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
22 Tenforde MW, Yadav A, Dowdy DW, Gupte N, Shivakoti R, Yang WT, Mwelase N, Kanyama C, Pillay S, Samaneka W, Santos B, Poongulali S, Tripathy S, Riviere C, Berendes S, Lama JR, Cardoso SW, Sugandhavesa P, Christian P, Semba RD, Campbell TB, Gupta A; NWCS319 and ACTG 5175 study team. Vitamin A and D Deficiencies Associated With Incident Tuberculosis in HIV-Infected Patients Initiating Antiretroviral Therapy in Multinational Case-Cohort Study. J Acquir Immune Defic Syndr 2017;75:e71-9. [PMID: 28169875 DOI: 10.1097/QAI.0000000000001308] [Cited by in Crossref: 28] [Cited by in F6Publishing: 29] [Article Influence: 4.7] [Reference Citation Analysis]
23 Sudfeld CR, Manji KP, Duggan CP, Aboud S, Muhihi A, Sando DM, Al-Beity FMA, Wang M, Fawzi WW. Effect of maternal vitamin D3 supplementation on maternal health, birth outcomes, and infant growth among HIV-infected Tanzanian pregnant women: study protocol for a randomized controlled trial. Trials 2017;18:411. [PMID: 28870263 DOI: 10.1186/s13063-017-2157-3] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
24 Schlereth F, Badenhoop K. [Vitamin D : More than just a bone hormone]. Internist (Berl) 2016;57:646-55. [PMID: 27307163 DOI: 10.1007/s00108-016-0082-2] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
25 Kalluri HV, Sacha LM, Ingemi AI, Shullo MA, Johnson HJ, Sood P, Tevar AD, Humar A, Venkataramanan R. Low vitamin D exposure is associated with higher risk of infection in renal transplant recipients. Clin Transplant 2017;31:e12955. [DOI: 10.1111/ctr.12955] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.7] [Reference Citation Analysis]
26 Sudfeld CR, Mugusi F, Aboud S, Nagu TJ, Wang M, Fawzi WW. Efficacy of vitamin D3 supplementation in reducing incidence of pulmonary tuberculosis and mortality among HIV-infected Tanzanian adults initiating antiretroviral therapy: study protocol for a randomized controlled trial. Trials 2017;18:66. [PMID: 28183335 DOI: 10.1186/s13063-017-1819-5] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 2.7] [Reference Citation Analysis]
27 Aibana O, Franke MF, Huang C, Galea JT, Calderon R, Zhang Z, Becerra MC, Smith ER, Ronnenberg AG, Contreras C, Yataco R, Lecca L, Murray MB. The Impact of Vitamin A and Carotenoids on the Risk of Tuberculosis Progression.. [DOI: 10.1101/095232] [Reference Citation Analysis]
28 Boillat-Blanco N, Bovet P, Ramaiya KL, Mganga M, Minja LT, Saleh L, Imboden M, Schindler C, Gagneux S, Daubenberger C, Reither K, Probst-Hensch N. Association between tuberculosis, diabetes and 25 hydroxyvitamin D in Tanzania: a longitudinal case control study. BMC Infect Dis 2016;16:626. [PMID: 27809789 DOI: 10.1186/s12879-016-1960-x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
29 Noor RA, Geldsetzer P, Bärnighausen T, Fawzi W. Do countries rely on the World Health Organization for translating research findings into clinical guidelines? A case study. Global Health 2016;12:58. [PMID: 27716252 DOI: 10.1186/s12992-016-0196-2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
30 Arnedo-pena A, Juan-cerdan JV, Romeu-garcia MA, Garcia-ferrer D, Iborra-millet J, Ferrero-vega JA, Bellido-blasco JB, Meseguer-ferrer N, Pardo-serrano F. Tuberculosis and Vitamin D Status Among the Contacts of Pulmonary Tuberculosis Patients. Avicenna J Clin Microbiol Infect 2016;4:36889-36889. [DOI: 10.17795/ajcmi-36889] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
31 Nylén H, Habtewold A, Makonnen E, Yimer G, Bertilsson L, Burhenne J, Diczfalusy U, Aklillu E. Prevalence and risk factors for efavirenz-based antiretroviral treatment-associated severe vitamin D deficiency: A prospective cohort study. Medicine (Baltimore) 2016;95:e4631. [PMID: 27559961 DOI: 10.1097/MD.0000000000004631] [Cited by in Crossref: 11] [Cited by in F6Publishing: 14] [Article Influence: 1.6] [Reference Citation Analysis]
32 Nunnari G, Fagone P, Lazzara F, Longo A, Cambria D, Di Stefano G, Palumbo M, Malaguarnera L, Di Rosa M. Vitamin D3 inhibits TNFα-induced latent HIV reactivation in J-LAT cells. Mol Cell Biochem 2016;418:49-57. [PMID: 27295094 DOI: 10.1007/s11010-016-2732-z] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.6] [Reference Citation Analysis]
33 Viard J. Vitamine D et pathologies infectieuses. Médecine Nucléaire 2015;39:430-434. [DOI: 10.1016/j.mednuc.2015.07.002] [Reference Citation Analysis]
34 Liu E, Makubi A, Drain P, Spiegelman D, Sando D, Li N, Chalamilla G, Sudfeld CR, Hertzmark E, Fawzi WW. Tuberculosis incidence rate and risk factors among HIV-infected adults with access to antiretroviral therapy. AIDS 2015;29:1391-9. [PMID: 26091295 DOI: 10.1097/QAD.0000000000000705] [Cited by in Crossref: 53] [Cited by in F6Publishing: 54] [Article Influence: 6.6] [Reference Citation Analysis]
35 Facchini L, Venturini E, Galli L, Martino MD, Chiappini E. Vitamin D and tuberculosis: a review on a hot topic. Journal of Chemotherapy 2015;27:128-38. [DOI: 10.1179/1973947815y.0000000043] [Cited by in Crossref: 32] [Cited by in F6Publishing: 32] [Article Influence: 4.0] [Reference Citation Analysis]
36 Keflie TS, Nölle N, Lambert C, Nohr D, Biesalski HK. Vitamin D deficiencies among tuberculosis patients in Africa: A systematic review. Nutrition 2015;31:1204-12. [PMID: 26333888 DOI: 10.1016/j.nut.2015.05.003] [Cited by in Crossref: 29] [Cited by in F6Publishing: 26] [Article Influence: 3.6] [Reference Citation Analysis]
37 Zeng J, Wu G, Yang W, Gu X, Liang W, Yao Y, Song Y. A serum vitamin D level <25nmol/l pose high tuberculosis risk: a meta-analysis. PLoS One 2015;10:e0126014. [PMID: 25938683 DOI: 10.1371/journal.pone.0126014] [Cited by in Crossref: 48] [Cited by in F6Publishing: 56] [Article Influence: 6.0] [Reference Citation Analysis]
38 Mansueto P, Seidita A, Vitale G, Gangemi S, Iaria C, Cascio A. Vitamin D Deficiency in HIV Infection: Not Only a Bone Disorder. Biomed Res Int 2015;2015:735615. [PMID: 26000302 DOI: 10.1155/2015/735615] [Cited by in Crossref: 59] [Cited by in F6Publishing: 63] [Article Influence: 7.4] [Reference Citation Analysis]
39 Eckard AR, McComsey GA. Vitamin D deficiency and altered bone mineral metabolism in HIV-infected individuals. Curr HIV/AIDS Rep 2014;11:263-70. [PMID: 24962286 DOI: 10.1007/s11904-014-0218-8] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 1.5] [Reference Citation Analysis]
40 Sudfeld CR, Duggan C, Aboud S, Kupka R, Manji KP, Kisenge R, Fawzi WW. Vitamin D status is associated with mortality, morbidity, and growth failure among a prospective cohort of HIV-infected and HIV-exposed Tanzanian infants. J Nutr 2015;145:121-7. [PMID: 25527666 DOI: 10.3945/jn.114.201566] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 2.6] [Reference Citation Analysis]
41 Griffin AT. Relationship between Vitamin D Nutritional Status and Human Immunodeficiency Virus Infection. Health of HIV Infected People 2015. [DOI: 10.1016/b978-0-12-800769-3.00012-3] [Reference Citation Analysis]
42 Morse CG, High KP. Nutrition, Immunity, and Infection. Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases 2015. [DOI: 10.1016/b978-1-4557-4801-3.00011-4] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
43 Gandhi V, Psevdos G, Felix LPL. The Role of Vitamin D in Human Immunodeficiency Virus Infection. Health of HIV Infected People 2015. [DOI: 10.1016/b978-0-12-800769-3.00011-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
44 Herzog R, Cunningham-rundles S. Malnutrition, Immunodeficiency, and Mucosal Infection. Mucosal Immunology 2015. [DOI: 10.1016/b978-0-12-415847-4.00074-4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
45 Arnedo-Pena A, Juan-Cerdán JV, Romeu-García MA, García-Ferrer D, Holguín-Gómez R, Iborra-Millet J, Pardo-Serrano F. Vitamin D status and incidence of tuberculosis infection conversion in contacts of pulmonary tuberculosis patients: a prospective cohort study. Epidemiol Infect 2015;143:1731-41. [PMID: 25274036 DOI: 10.1017/S0950268814002386] [Cited by in Crossref: 28] [Cited by in F6Publishing: 32] [Article Influence: 3.1] [Reference Citation Analysis]
46 Coussens AK, Martineau AR, Wilkinson RJ. Anti-Inflammatory and Antimicrobial Actions of Vitamin D in Combating TB/HIV. Scientifica (Cairo) 2014;2014:903680. [PMID: 25101194 DOI: 10.1155/2014/903680] [Cited by in Crossref: 32] [Cited by in F6Publishing: 40] [Article Influence: 3.6] [Reference Citation Analysis]
47 Gao WW, Wang Y, Zhang XR, Yin CY, Hu CM, Tian M, Wang HW, Zhang X. Levels of 1,25(OH)2D3 for patients with pulmonary tuberculosis and correlations of 1,25(OH)2D3 with the clinical features of TB. J Thorac Dis 2014;6:760-4. [PMID: 24977000 DOI: 10.3978/j.issn.2072-1439.2014.05.12] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
48 Escota GV, Cross S, Powderly WG. Vitamin D and calcium abnormalities in the HIV-infected population. Endocrinol Metab Clin North Am 2014;43:743-67. [PMID: 25169565 DOI: 10.1016/j.ecl.2014.05.005] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
49 He X, Yan J, Zhu X, Wang Q, Pang W, Qi Z, Wang M, Luo E, Parker DM, Cantorna MT, Cui L, Cao Y. Vitamin D inhibits the occurrence of experimental cerebral malaria in mice by suppressing the host inflammatory response. J Immunol 2014;193:1314-23. [PMID: 24965778 DOI: 10.4049/jimmunol.1400089] [Cited by in Crossref: 47] [Cited by in F6Publishing: 48] [Article Influence: 5.2] [Reference Citation Analysis]
50 Jarvis JN, Bicanic T, Loyse A, Meintjes G, Hogan L, Roberts CH, Shoham S, Perfect JR, Govender NP, Harrison TS. Very low levels of 25-hydroxyvitamin D are not associated with immunologic changes or clinical outcome in South African patients with HIV-associated cryptococcal meningitis. Clin Infect Dis 2014;59:493-500. [PMID: 24825871 DOI: 10.1093/cid/ciu349] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
51 Havers F, Smeaton L, Gupte N, Detrick B, Bollinger RC, Hakim J, Kumarasamy N, Andrade A, Christian P, Lama JR, Campbell TB, Gupta A; ACTG PEARLS., NWCS 319 Study Teams. 25-Hydroxyvitamin D insufficiency and deficiency is associated with HIV disease progression and virological failure post-antiretroviral therapy initiation in diverse multinational settings. J Infect Dis 2014;210:244-53. [PMID: 24799602 DOI: 10.1093/infdis/jiu259] [Cited by in Crossref: 45] [Cited by in F6Publishing: 45] [Article Influence: 5.0] [Reference Citation Analysis]
52 Borella E, Nesher G, Israeli E, Shoenfeld Y. Vitamin D: a new anti-infective agent? Ann N Y Acad Sci. 2014;1317:76-83. [PMID: 24593793 DOI: 10.1111/nyas.12321] [Cited by in Crossref: 60] [Cited by in F6Publishing: 64] [Article Influence: 6.7] [Reference Citation Analysis]
53 Mehta S, Mugusi FM, Bosch RJ, Aboud S, Urassa W, Villamor E, Fawzi WW. Vitamin D status and TB treatment outcomes in adult patients in Tanzania: a cohort study. BMJ Open. 2013;3:e003703. [PMID: 24247327 DOI: 10.1136/bmjopen-2013-003703] [Cited by in Crossref: 21] [Cited by in F6Publishing: 26] [Article Influence: 2.1] [Reference Citation Analysis]
54 Legeai C, Vigouroux C, Souberbielle JC, Bouchaud O, Boufassa F, Bastard JP, Carlier R, Capeau J, Goujard C, Meyer L, Viard JP; ANRS-COPANA Cohort Study Group. Associations between 25-hydroxyvitamin D and immunologic, metabolic, inflammatory markers in treatment-naive HIV-infected persons: the ANRS CO9 «COPANA» cohort study. PLoS One 2013;8:e74868. [PMID: 24058636 DOI: 10.1371/journal.pone.0074868] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 2.3] [Reference Citation Analysis]
55 Ghosn J, Viard JP. [Vitamin D and infectious diseases]. Presse Med 2013;42:1371-6. [PMID: 24051165 DOI: 10.1016/j.lpm.2013.07.009] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
56 Sudfeld CR, Mugusi FM, Fawzi WW. Reply to Séraphin. The Journal of Infectious Diseases 2013;207:1623-1623. [DOI: 10.1093/infdis/jit074] [Reference Citation Analysis]
57 Martineau AR. Vitamin D: an adjunct to antiretroviral therapy? J Infect Dis 2013;207:373-5. [PMID: 23162134 DOI: 10.1093/infdis/jis697] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]